According to a research report published by Spherical Insights & Consulting, the Global Multi-omics Market Size is Expected to Grow from USD 2.59 Billion in 2023 to USD 10.72 Billion by 2033, at a CAGR of 15.26% during the forecast period 2023-2033.

Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/4406

Multi-omics is an integrative approach that combines data from multiple biological ‘omics’ layers to provide a comprehensive understanding of biological systems, diseases, or processes. Each ‘omics’ field represents a specific layer of biological information, such as genomics, transcriptomics proteomics, metabolomics, and epigenomics. Genomics is the primary property involved and encompasses the architecture and operation of the genome. Investigates the solutions of transcription transcribed from a genome through RNA sequencing, whereas Proteomics defines and investigates protein expression through the associated analytical methods, for instance, mass spectroscopy. Metabolomics studies small-molecule metabolites and aids in recognizing metabolic pathways. Furthermore, the purpose of personalized medicine is to modify medical interventions and treatments to each patient’s unique characteristics, such as metabolic profiles, protein expression levels, and genetic composition. Also, growing government programs and higher expenditures have become key factors propelling the market’s expansion. There is great potential for multi-omics to enhance biological interpretation and enhance human health. However, the high costs of multi-omics technologies, data integration challenges, limited skilled professionals, lack of standardized protocols, and concerns over data privacy.

Browse key industry insights spread across 288 pages with 110 Market data tables and figures & charts from the report on the Global Multi-omics Market Size, Share, and COVID-19 Impact Analysis, By Type (Single-cell Omics and Bulk Omics), By Platform (Genomics, Transcriptomics, Proteomics, Metabolomics, and Integrated Omics Platform), By Application (Cell Biology, Oncology, Neurology, Immunology, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.

Buy Now Full Report: https://www.sphericalinsights.com/checkout/4406

The single-cell omics segment is expected to hold the greatest share of the global multi-omics market over the projected timeframe.

Based on type, the global multi-omics market is categorized into single-cell omics and bulk omics. Among these, the single-cell omics segment is expected to hold the greatest share of the global multi-omics market over the projected timeframe. This is due to their capacity to capture complex molecular signatures at the single-cell level, which allows for a more comprehensive and accurate representation of biological functions.

The genomic segment is expected to hold the greatest share of the global multi-omics market over the predicted timeframe.

Based on platform, the global multi-omics market is categorized into genomics, transcriptomics, proteomics, metabolomics, and integrated omics platforms. Among these, the genomic segment is expected to hold the greatest share of the global multi-omics market over the predicted timeframe. The segmental growth due to high-production sequencing technologies, combined with reduced costs and improved figuring capabilities, have driven market expansion and researchers’ attempts to realize the enormous potential of genomic data and its expanding application in personalized medicine.

The oncology segment is expected to hold the greatest share of the global multi-omics market over the projected timeframe.

Based on application, the global multi-omics market is categorized into cell biology, oncology, neurology, immunology, and others. Among these, the oncology segment is expected to hold the greatest share of the global multi-omics market over the projected timeframe. This is attributed to the increasing cases of cancer and the rising use of multi-omics for cancer drive the market. Also, Numerous attempts are being made by scientists and entrepreneurs to use multi-omics techniques to support cancer patients.

Inquire Before Buying This Research Report: https://www.sphericalinsights.com/inquiry-before-buying/4406

North America is expected to hold the greatest share of the global multi-omics market over the projected timeframe.

North America is expected to hold the greatest share of the global multi-omics market over the projected timeframe. The most major profit share is provided by the leading market companies in this sector. Additionally, companies are taking steps to reinforce their presence in several methods that range which is propelling local industries. The U.S.-based business Tempus partnered with Actuate Therapeutics in February 2023 to assist in identifying and confirming the biomarker profile of cancer patients. In this project, Tempus utilizes the multi-omics approach to improve research and develop novel scientific discoveries. during the forecast period, these tactics will contribute to the multi-omics market’s growth.

Asia Pacific is anticipated to grow at a rapid rate in the global multi-omics market over the projected timeframe. An increasing number of chronic illnesses, the acquisition of products for analysis and visualization from around the world, technological advancements, and rising research and development (R&D) funding are some of the factors driving this region’s growth. In the Asia-Pacific region, these factors are propelling the multi-omics market’s expansion over the forecast period.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global multi-omics market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Major vendors in the global multi-omics market are Illumina Inc., PerkinElmer Inc., Bruker, BD, QIAGEN, Thermo Fisher Scientific Inc., BGI, Agilent Technologies, Inc., Danaher, Shimadzu Corporation, 10x Genomics, CYTENA GmbH, Becton, Dickinson and Company, and others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Key Market Development

• In January 2024, BD established its collaboration with Hamilton Company. Through this collaboration, the company focuses on developing automated applications reagent kits that are compatible with robotics to standardize and reduce human error in large-scale single-cell multi-omics experiments.
• In January 2024, A license and distribution agreement was signed between Akoya Biosciences, Inc. and Thermo Fisher Scientific Inc. that offers a combined solution for spatial multi-omics workflows. The agreement makes it feasible to simplify the whole-slide, multi-omics imaging process. By analysing protein and RNA, this combined method offers a more thorough understanding of cell phenotypes and conditions, which is essential for fields in cancer research.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global multi-omics market based on the below-mentioned segments

Global Multi-omics Market, By Type

• Single-cell Omics
• Bulk Omics

Global Multi-omics Market, By Platform

• Genomics
• Transcriptomics
• Proteomics
• Metabolomics
• Integrated Omics Platform

Global Multi-omics Market, By Application

• Cell Biology
• Oncology
• Neurology
• Immunology
• Others

Global Multi-omics Market, Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

Browse Related URL:

Global Specialty Enzymes Market Size, Share, and COVID-19 Impact Analysis, By Source (Plants, Animal, and Microorganisms), By Product (Carbohydrase, Proteases, Lipases, Polymerases & Nucleases, and Others), By Application (Pharmaceutical, Research & Biotechnology, Diagnostics, and Biocatalyst), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035

France Antidote Market Size, Share, and COVID-19 Impact Analysis, By Type (Chemical Antidote, Physical Antidote, and Pharmacological Antidote), By Route of Administration (Oral, Topical, and Injectable), and France Antidote Market Insights, Industry Trend, Forecasts to 2035

Asia Pacific Hospital Supplies Market Size, Share, and COVID-19 Impact Analysis, By Product (Patient Examination Devices, Operating Room Equipments, Mobility Aids & Transportation Equipments, Sterilization and Disinfectant Equipments, and Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centres, Diagnostic Centres, Long Term Care Centres, and Nursing Facilities), and Asia Pacific Hospital Supplies Market Insights, Industry Trend, Forecasts to 2035.

South Korea Digital X-Ray Market Size, Share, and COVID-19 Impact Analysis, By Technology (Computed Radiography, Direct Radiography), By Portability (Fixed Systems, Portable Systems), and South Korea Digital X-Ray Market Insights, Industry Trend, Forecasts to 2035

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company’s mission is to work with businesses to achieve business objectives and maintain strategic improvements.

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter